Posting of Annual Report and AGM Notice

RNS Number : 4485B

Immupharma PLC

17 April 2012

 



FOR IMMEDIATE RELEASE

17 April 2012

ImmuPharma plc

Annual Report and Accounts

Notice of Annual General Meeting: 23 May 2012

In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM: IMM) (the "Company") the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2011 has been posted to shareholders.

The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.

The Company's Annual General Meeting will be held on 23 May 2012 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London SW1H 0BL.

- Ends -

For further information please contact:

ImmuPharma plc	+ 44 (0) 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Lisa Baderoon, Head of Investor Relations	+ 44 (0) 7721 413496
Buchanan	+ 44 (0) 20 7466 5000
Mark Court
Jessica Fontaine
Panmure, Gordon & Co., NOMAD & Broker	[phone]
Andrew Burnett
Fred Walsh
Espirito Santo Investment Bank	[phone]
James Bromhead
Richard Crawley

 

END

 

 

MSCSFLEFMFESESL